PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy.

Journal: Technology in cancer research & treatment
PMID:

Abstract

BACKGROUND AND PURPOSE: This study explored the association between a single-nucleotide polymorphism of prostate stem cell antigen and prostate cancer in Chinese patients undergoing prostate biopsy.

Authors

  • Xuefeng Zhang
    Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Qin Hu
    School of pharmacy, Nanjing medical university, Nanjing, Jiangsu, 211166, People's Republic of China. huqin@njmu.edu.cn.
  • Ye Chen
    1 Department of Urology, First Affiliated Hospital of Soochow University, Suzhou, China.
  • Miao Li
    School of Computer Science and TechnologyHuazhong University of Science and Technology Wuhan 430074 China.
  • Huming Yin
    1 Department of Urology, First Affiliated Hospital of Soochow University, Suzhou, China.
  • Chenchao Zhou
    1 Department of Urology, First Affiliated Hospital of Soochow University, Suzhou, China.
  • Gang Li
    The Centre for Cyber Resilience and Trust, Deakin University, Australia.
  • Jianquan Hou
    1 Department of Urology, First Affiliated Hospital of Soochow University, Suzhou, China.